Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Post by sharp662on Jan 20, 2012 9:59pm

622 Views

Post# 19430148

GPD Insider selling

Insider selling today. Anyone know if its related to warrants or PP?

https://www.tmxmoney.com/HttpController?GetPage=InsiderTradeMarker&Language=en

Top 10 Stocks By Net Sells Volume
Symbol Company Name Insider Buys Volume Insider Sells Volume Net Sells Volume
PRU Perseus Mining Limited 0 592,000 592,000
RGT Rockgate Capital Corp. 0 519,000 519,000
GPD Golden Predator Corp. 0 118,500 118,500
AAB Aberdeen International Inc. 0 73,500 73,500
SAS St Andrew Goldfields Ltd. 0 66,000 66,000
AVF AvenEx Energy Corp. 0 48,800 48,800
CIX CI Financial Corp. 0 32,040 32,040
BRY Bri-Chem Corp. 0 30,000 30,000
DNG Dynacor Gold Mines Inc. 0 21,500 21,500
KOR Corvus Gold Inc. 0 15,000 15,000